BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 2941035)

  • 1. Recurrent herpes genitalis, severe impairment of specific cell-mediated immune response and bilateral femoral head necrosis: report of a case.
    Sirianni MC; Soddu S; Bonomo R; Panà A
    Boll Ist Sieroter Milan; 1986; 65(1):78-83. PubMed ID: 2941035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological responses of patients with recurrent herpes genitalis.
    Sirianni MC; Bonomo R; Scarpati B; Soddu S; Panà A; Turbessi G; Cherchi M; Aiuti F
    Diagn Immunol; 1986; 4(6):294-8. PubMed ID: 3493109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coinfection with herpes simplex virus type 2 is associated with reduced HIV-specific T cell responses and systemic immune activation.
    Sheth PM; Sunderji S; Shin LY; Rebbapragada A; Huibner S; Kimani J; Macdonald KS; Ngugi E; Bwayo JJ; Moses S; Kovacs C; Loutfy M; Kaul R
    J Infect Dis; 2008 May; 197(10):1394-401. PubMed ID: 18444797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-mediated immunity and immunosuppression in herpes simplex virus infection.
    Rinaldo CR; Torpey DJ
    Immunodeficiency; 1993; 5(1):33-90. PubMed ID: 8167747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen-specific T cells localize to the uterine cervix in women with genital herpes simplex virus type 2 infection.
    Koelle DM; Schomogyi M; Corey L
    J Infect Dis; 2000 Sep; 182(3):662-70. PubMed ID: 10950757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. II. Bifunctional clones with cytotoxic and virus-induced proliferative activities exhibit herpes simplex virus type 1 and 2 specific or type common reactivities.
    Yasukawa M; Zarling JM
    J Immunol; 1984 Nov; 133(5):2736-42. PubMed ID: 6207243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Holy Grail: immune control of human herpes simplex virus infection and disease.
    Cunningham AL; Mikloska Z
    Herpes; 2001 Mar; 8 Suppl 1():6A-10A. PubMed ID: 11867028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex virus type 2.
    Parr MB; Kepple L; McDermott MR; Drew MD; Bozzola JJ; Parr EL
    Lab Invest; 1994 Mar; 70(3):369-80. PubMed ID: 8145530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subtly impaired humoral immunity predisposes to frequently recurring genital herpes simplex virus type 2 infection and herpetic neuralgia.
    Seppanen M; Meri S; Notkola IL; Seppala IJ; Hiltunen-Back E; Sarvas H; Lappalainen M; Valimaa H; Palikhe A; Valtonen VV; Lokki ML
    J Infect Dis; 2006 Sep; 194(5):571-8. PubMed ID: 16897653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of herpes simplex virus-specific T cells in the murine female genital tract following genital infection with herpes simplex virus type 2.
    Milligan GN; Bernstein DI
    Virology; 1995 Oct; 212(2):481-9. PubMed ID: 7571418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T lymphocytes are required for protection of the vaginal mucosae and sensory ganglia of immune mice against reinfection with herpes simplex virus type 2.
    Milligan GN; Bernstein DI; Bourne N
    J Immunol; 1998 Jun; 160(12):6093-100. PubMed ID: 9637526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of cell-mediated immune response in patients with recurrent herpes simplex treated with decaris].
    Olszewska Z; Dabkowski R; Kubasiewicz M
    Przegl Dermatol; 1988; 75(1):17-23. PubMed ID: 3260388
    [No Abstract]   [Full Text] [Related]  

  • 13. T-cell-mediated mechanisms involved in resolution of genital herpes simplex virus type 2 (HSV-2) infection of mice.
    Milligan GN; Dudley-McClain KL; Young CG; Chu CF
    J Reprod Immunol; 2004 Apr; 61(2):115-27. PubMed ID: 15063634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isopentenyl pyrophosphate-reactive Vgamma9Vdelta 2 T helper 1-like cells are the major gammadelta T cell subset recovered from lesions of patients with genital herpes.
    Verjans GM; Roest RW; van der Kooi A; van Dijk G; van der Meijden WI; Osterhaus A'
    J Infect Dis; 2004 Aug; 190(3):489-93. PubMed ID: 15243921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevention and therapy of herpesvirus infections].
    Abb J
    Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Feb; 180(2-3):107-20. PubMed ID: 2986378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunity to herpes simplex virus type 2. IV. Impaired lymphokine production during recrudescence correlates with an imbalance in T lymphocyte subsets.
    Sheridan JF; Donnenberg AD; Aurelian L; Elpern DJ
    J Immunol; 1982 Jul; 129(1):326-31. PubMed ID: 7045224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent herpes simplex virus type 2 meningitis: a case report of Mollaret's meningitis.
    Kojima Y; Hashiguchi H; Hashimoto T; Tsuji S; Shoji H; Kazuyama Y
    Jpn J Infect Dis; 2002 Jun; 55(3):85-8. PubMed ID: 12195049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Herpes simplex infection as a sexually transmitted disease].
    Stary A; Söltz-Szöts J
    Wien Klin Wochenschr; 1983 Dec; 95(23):823-7. PubMed ID: 6689458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular interactions in the cytotoxic T lymphocyte response to herpes simplex virus antigens: differential antigen activation requirements for the helper T lymphocyte and cytotoxic T lymphocyte precursors.
    Schmid DS; Rouse BT
    J Immunol; 1983 Jul; 131(1):479-84. PubMed ID: 6223080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the IFN-gamma T-cell responses to immediate early antigens in humans with genital herpes.
    Braun RP; Payne LG; Dong L
    Virol J; 2006 Jul; 3():54. PubMed ID: 16822314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.